STTR Phase I: Wireless Sensing of Body Movement: Detection and Evaluation of Lameness in Horses

Award Information
Agency:
National Science Foundation
Branch
n/a
Amount:
$149,912.00
Award Year:
2008
Program:
STTR
Phase:
Phase I
Contract:
0809450
Award Id:
88520
Agency Tracking Number:
0809450
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
2404 Cimarron Drive, Columbia, MO, 65203
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
800123254
Principal Investigator:
Allyn GMann
NoDeg
(573) 268-5253
allynmann@everestkc.net
Business Contact:
Allyn GMann
NoDeg
(573) 268-5253
allynmann@everestkc.net
Research Institute:
University of Missouri - Columbia
Michael Nichols
2404 Cimarron Dr
340A Bond Life Sciences Center
Columbia, MO, 65203
(573) 882-6726
Nonprofit college or university
Abstract
This Small Business Technology Transfer Phase I project focuses on lameness which is one of the most common health problems for horses. Treatment is most effective in the earliest stages of lameness, however the subjective diagnostic methods currently used by large animal are imprecise and inaccurate. To improve the quality of lameness evaluation, the startup company Equinosis is leversaging research at the University of Missouri to develop a field-ready, portable, wireless body-sensor-based system that can diagnose the affected limb and severity of lameness in horses sooner and more effectively than current methods. This computer-driven technology determines the degree of lameness by measuring the head and pelvic movements of horses. In the proposed project, Equinosis will evaluate the patterns of head and pelvic motions of horses with definite diagnoses of naturally-occurring and experimentally-induced (temporary) lameness. The objective of this work will be to verify both the technology and University of Missouri research data. The broader impacts of this research may extend beyond the initial goals of improved diagnosis and earlier, more effective treatment of lameness in horses. While Equinosis has identified lameness in horses as its initial commercialization target, the company believes that this patent-pending technology can be extended to detect other ailments in other animal species. Further development of the technology could eventually assist in the diagnosis of medical issues for humans, especially in those cases where the patient has referred pain or cannot communicate symptoms clearly to medical professionals.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government